“Provider status” is one of those terms that is easily recognized by members of the profession of pharmacy but sometimes has numerous meanings depending on its context.

Ilisa Bernstein, PharmD, JD, FAPhA, and E. Michael Murphy, PharmD, MBA

In November 2024, Azurity announced the approval of Danziten (nilotinib), indicated for adults with newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in the chronic phase (CP) and adults with CP and accelerated phase (AP) Ph+ CML resistant to or intolerant to prior therapy that included imatinib.

Institute for Safe Medication Practice, Plymouth Meeting, PA

Pharmacists are the best experts on medication safety in an institutional setting. When a nursing error is alleged to have occurred, a medication safety pharmacist will likely be asked to provide testimony in legal proceedings that may arise.

David B. Brushwood, BSPharm, JD

Food insecurity—defined as inadequate food or food that lacks nutrition—has quickly become another social determinant of health (SDOH) that could be addressed in a range of environments, including health care settings.

Loren Bonner

An AARP Public Policy Institute Spotlight report from early 2025 found that prices for the top 25 Medicare Part D drugs not yet scheduled for Medicare price negotiation have nearly doubled since entering the market, increasing by an average of 98%.

Kevin Willmann